✦ LIBER ✦

113 A phase 2 dose-escalation study of albuferon combined with ribavirin in non-responders to prior interferon-based therapy for chronic hepatitis C infection

✍ Scribed by V. Rustgi; D. Nelson; V. Balan; M. Sulkowski; L. Lambiase; G. Davis; A. Muir; R. Dickson; R. Wiesner; A. Neumann; B. Osborn; R. Yu; P. Cronin; W. Freimuth; J. McHutchison; M. Subramanian

Book ID: 117374393
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 108 KB
Volume: 44
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(06)80114-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon alpha-2A in combination thera

Interferon alpha-2A in combination therapies for the treatment of chronic hepatitis C in prior non-responders to interferon monotherapy

✍ J. Salmeron; M. Diago; R. Andrade; R. Perez; R. Sola; M. Romero; M. De La Mata; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB

A combined therapy with high dose of int

A combined therapy with high dose of interferon (IFN)-alpha as an induction and ribavirin in non-responders to IFN alone with chronic hepatitis C

✍ Takashimizu, Shinji; Watanabe, Norihito; Mine, Tetsuya; Matsuzaki, Shohei 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 252 KB

A randomized trial of high dose interfer

A randomized trial of high dose interferon alfa-2b with or without ribavirin for chronic hepatitis C in non-responders to standard dose interferon

✍ Shiva Kumar, K.; Malik, Arshad H.; Malet, Peter F.; Ostapowicz, George; Wood, Me 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Induction doses of interferon-α-2a in co

Induction doses of interferon-α-2a in combination with ribavirin and/or amantadine for the treatment of chronic hepatitis C in non-responders to interferon monotherapy: a randomized trial

✍ J. Salmerón; M. Diago; R. Andrade; R. Pérez; R. Solá; M. Romero; M. De La Mata; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 542 KB

492 A phase II, placebo-controlled study

492 A phase II, placebo-controlled study of merimepodib (XV-497), in combination with pegylated interferon-alfa, and ribavirin in patients with chronic hepatitis C non-responsive to previous therapy with interferon-alfa and ribavirin

✍ P. Marcellin; Y. Horsmans; F. Nevens; J.D. Grange; J.P. Bronowicki; D. Vetter; R 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 63 KB

457 Retreatment with pegylated interfero

457 Retreatment with pegylated interferon alpha-2B and ribavirin in patients with chronic hepatitis C non responders to interferon monotherapy or interferon and ribavirin combination. A prospective randomized pilote study of two regimens: Induction versus REG

✍ C. Bapin; P. Fabbro-Peray; S. Hachemane; F. Blanc; D. Diaz; P. Pueyo; D. Larrey 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 63 KB